Distribution of gender, age group and comorbidity in individuals with and without schizophrenia
| Number of (%) of individuals | p Value | ||
|---|---|---|---|
| With schizophrenia | Without schizophrenia | ||
| Variable | n=2338 | n=7014 | |
| Gender | 1 | ||
| Female | 1120 (47.9) | 3360 (47.9) | |
| Male | 1218 (52.1) | 3654 (52.1) | |
| Age group | 1 | ||
| 18–29 | 739 (31.61) | 2217 (31.61) | |
| 30–39 | 576 (24.64) | 1728 (24.64) | |
| 40–49 | 502 (21.47) | 1506 (21.47) | |
| 50–59 | 255 (10.91) | 765 (10.91) | |
| 60–69 | 128 (5.47) | 384 (5.47) | |
| ≥70 | 138 (5.9) | 414 (5.9) | |
| Income | <0.001 | ||
| <18 000 | 1571 (67.19) | 3155 (44.98) | |
| 18 000–34 999 | 673 (28.79) | 2591 (36.94) | |
| ≥35 000 | 94 (4.02) | 1268 (18.08) | |
| Urbanisation* | <0.001 | ||
| 1 | 526 (22.5) | 1980 (28.23) | |
| 2 | 169 (7.23) | 597 (8.51) | |
| 3 | 583 (24.94) | 1757 (25.05) | |
| 4 | 1060 (45.34) | 2680 (38.21) | |
| Geography | <0.001 | ||
| North | 1067 (45.60) | 3669 (52.30) | |
| Central | 461 (19.70) | 1224 (17.50) | |
| South | 734 (31.40) | 1984 (28.30) | |
| East | 76 (3.30) | 137 (2.00) | |
| Comorbidity | |||
| Hypertension | 420 (17.96) | 1097 (15.64) | <0.05 |
| Diabetes mellitus | 218 (9.32) | 500 (7.13) | <0.001 |
| Dyslipidaemia | 272 (11.63) | 766 (10.92) | 0.342 |
| Obesity | 27 (1.20) | 39 (0.60) | <0.05 |
| Heart disease | 343 (14.70) | 721 (10.30) | <0.001 |
| Medication | |||
| NSAIDs use | 960 (41.06) | 2366 (33.73) | <0.001 |
*Urbanisation level from 1 to 4 indicates most to least urbanised.
NSAIDs, non-steroidal anti-inflammatory drugs.